Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by DatAssBanditon Sep 03, 2018 10:22pm
174 Views
Post# 28557109

RE:RE:RE:RE:RE:RE:Oct 17 , 40c , what are you waiting?

RE:RE:RE:RE:RE:RE:Oct 17 , 40c , what are you waiting?
Unbeliev789Lan wrote:
No further ahead is right on. However look at the Jan 2018 rise so there is money to make. It will drop like a rock as many will but jump in while the prices are low and sell quick.


I dont know why people say that the spike in late December is exclusive to pot stocks. Tons of stocks popped at that time and to me it seems like it was following cryptos. Even canadian real estate prices went insane at that time. I dont understand economics well enough to say what occurred during that period.... but I feel pot stocks just followed that trend along other stocks. Now pot has broken off on it's own due to legalization and KALY is not a pot stock and has nothing to do with Octobers lagalization. Anyways, I think you are right that there will be a run soon, but I feel like it will be due to manipulation and kaly short term investors should take advantage and sell. Maybe reload after the drop of you want to invest long term.
Bullboard Posts